Here, we detected higher TGFBR2 expression in triple‐negative tumors compared to luminal‐like tumors (Fig. 1C) as well as in ER‐negative compared to ER‐positive breast tumor tissue (Fig. 1D). The gene discussed is TGFBR2; the disease is breast neoplasm.